Spinal high-mobility group box 1 contributes to mechanical allodynia in a rat model of bone cancer pain

Biochemical and Biophysical Research Communications

Volumn 395, Issue 4, 2010, Pages 572-576

  Tong, Wei ^a   Wang, Wei ^b   Huang, Jing ^b   Ren, Ning ^a   Wu, Sheng Xi ^b   Li, Yong Qi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone cancer pain; High mobility group box 1; Rat; Spinal cord; Toll like receptors

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; INTERLEUKIN 1BETA; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE CANCER; BONE DESTRUCTION; BONE INJURY; BREAST CANCER; CANCER CELL; CANCER PAIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE MODEL; DRUG TARGETING; FEMALE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; SPINAL CORD; SYNAPTIC TRANSMISSION; TIBIA; WISTAR RAT;

ANIMALS; BONE NEOPLASMS; DISEASE MODELS, ANIMAL; FEMALE; HMGB1 PROTEIN; INTERLEUKIN-1BETA; PAIN; RATS; RATS, WISTAR; SPINAL CORD; STRESS, MECHANICAL; SYNAPTIC TRANSMISSION; UP-REGULATION;

RATTUS;

EID: 77952102555     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.04.086     Document Type: Article

References (24)

1. Goblirsch M.J., Zwolak P.P., and Clohisy D.R. Biology of bone cancer pain. Clin. Cancer Res. 12 (2006) 6231-6235
2. Kirou-Mauro A.M., Hird A., Wong J., Sinclair E., Barnes E.A., Tsao M., Danjoux C., and Chow E. Has pain management in cancer patients with bone metastases improved? A seven-year review at an outpatient palliative radiotherapy clinic. J. Pain Symptom Manage. 37 (2009) 77-84
3. Brainin-Mattos J., Smith N.D., Malkmus S., Rew Y., Goodman M., Taulane J., and Yaksh T.L. Cancer-related bone pain is attenuated by a systemically available delta-opioid receptor agonist. Pain 122 (2006) 174-181
4. Wakabayashi H., Hiraga T., and Yoneda T. Mechanism of cancer-induced bone pain. Clin. Calcium 16 (2006) 605-611
5. Honore P., Rogers S.D., Schwei M.J., Salak-Johnson J.L., Luger N.M., Sabino M.C., Clohisy D.R., and Mantyh P.W. Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons. Neuroscience 98 (2000) 585-598
6. Zhang R.X., Liu B., Li A., Wang L., Ren K., Qiao J.T., Berman B.M., and Lao L. Interleukin 1beta facilitates bone cancer pain in rats by enhancing NMDA receptor NR-1 subunit phosphorylation. Neuroscience 154 (2008) 1533-1538
7. Lotze M.T., and Tracey K.J. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat. Rev. Immunol. 5 (2005) 331-342
8. O'Connor K.A., Hansen M.K., Rachal Pugh C., Deak M.M., Biedenkapp J.C., Milligan E.D., Johnson J.D., Wang H., Maier S.F., Tracey K.J., and Watkins L.R. Further characterization of high mobility group box 1 (HMGB1) as a proinflammatory cytokine: central nervous system effects. Cytokine 24 (2003) 254-265
9. Kim J.B., Lim C.M., Yu Y.M., and Lee J.K. Induction and subcellular localization of high-mobility group box-1 (HMGB1) in the postischemic rat brain. J. Neurosci. Res. 86 (2008) 1125-1131
10. Wang Q., Ding Q., Zhou Y., Gou X., Hou L., Chen S., Zhu Z., and Xiong L. Ethyl pyruvate attenuates spinal cord ischemic injury with a wide therapeutic window through inhibiting high-mobility group box 1 release in rabbits. Anesthesiology 110 (2009) 1279-1286
11. Lo Coco D., Veglianese P., Allievi E., and Bendotti C. Distribution and cellular localization of high mobility group box protein 1 (HMGB1) in the spinal cord of a transgenic mouse model of ALS. Neurosci. Lett. 412 (2007) 73-77
12. Mao-Ying Q.L., Zhao J., Dong Z.Q., Wang J., Yu J., Yan M.F., Zhang Y.Q., Wu G.C., and Wang Y.Q. A rat model of bone cancer pain induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Biochem. Biophys. Res. Commun. 345 (2006) 1292-1298
13. Urch C.E., Donovan-Rodriguez T., and Dickenson A.H. Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain. Pain 106 (2003) 347-356
14. Yang H., Ochani M., Li J., Qiang X., Tanovic M., Harris H.E., Susarla S.M., Ulloa L., Wang H., DiRaimo R., Czura C.J., Roth J., Warren H.S., Fink M.P., Fenton M.J., Andersson U., and Tracey K.J. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc. Natl. Acad. Sci. USA 101 (2004) 296-301
15. Chaplan S.R., Bach F.W., Pogrel J.W., Chung J.M., and Yaksh T.L. Quantitative assessment of tactile allodynia in the rat paw. J. Neurosci. Methods 53 (1994) 55-63
16. Mitola S., Belleri M., Urbinati C., Coltrini D., Sparatore B., Pedrazzi M., Melloni E., and Presta M. Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine. J. Immunol. 176 (2006) 12-15
17. Yao X., Zhao G., Yang H., Hong X., Bie L., and Liu G. Overexpression of high-mobility group box 1 correlates with tumor progression and poor prognosis in human colorectal carcinoma. J. Cancer Res. Clin. Oncol. 136 (2009) 667-684
18. van Zoelen M.A., Yang H., Florquin S., Meijers J.C., Akira S., Arnold B., Nawroth P.P., Bierhaus A., Tracey K.J., and van der Poll T. Role of toll-like receptors 2 and 4, and the receptor for advanced glycation end products in high-mobility group box 1-induced inflammation in vivo. Shock 31 (2009) 280-284
19. Guo L.H., and Schluesener H.J. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell. Mol. Life Sci. 64 (2007) 1128-1136
20. Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., Choi S.Y., Park K., Kim J.S., Akira S., Na H.S., Oh S.B., and Lee S.J. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J. Biol. Chem. 282 (2007) 14975-14983
21. Tanga F.Y., Nutile-McMenemy N., and DeLeo J.A. The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc. Natl. Acad. Sci. USA 102 (2005) 5856-5861
22. Lan L.S., Ping Y.J., Na W.L., Miao J., Cheng Q.Q., Ni M.Z., Lei L., Fang L.C., Guang R.C., Jing Z., and Wei L. Down-regulation of toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol. Pain 6 (2010) 2
23. Hutchinson M.R., Ramos K.M., Loram L.C., Wieseler J., Sholar P.W., Kearney J.J., Lewis M.T., Crysdale N.Y., Zhang Y., Harrison J.A., Maier S.F., Rice K.C., and Watkins L.R. Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats. Neuroscience 164 (2009) 1821-1832
24. Wang W., Mei X., Huang J., Wei Y., Wang Y., Wu S., and Li Y. Crosstalk between spinal astrocytes and neurons in nerve injury-induced neuropathic pain. PLoS ONE 4 (2009) e6973